162 related articles for article (PubMed ID: 34831374)
1. MiR 208a Regulates Mitochondrial Biogenesis in Metabolically Challenged Cardiomyocytes.
Mekala N; Kurdys J; Vicenzi AP; Weiler LR; Avramut C; Vazquez EJ; Ragina N; Rosca MG
Cells; 2021 Nov; 10(11):. PubMed ID: 34831374
[TBL] [Abstract][Full Text] [Related]
2. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
[TBL] [Abstract][Full Text] [Related]
3. Secretory products from epicardial adipose tissue from patients with type 2 diabetes impair mitochondrial β-oxidation in cardiomyocytes via activation of the cardiac renin-angiotensin system and induction of miR-208a.
Blumensatt M; Fahlbusch P; Hilgers R; Bekaert M; Herzfeld de Wiza D; Akhyari P; Ruige JB; Ouwens DM
Basic Res Cardiol; 2017 Jan; 112(1):2. PubMed ID: 27864612
[TBL] [Abstract][Full Text] [Related]
4. MiR-208a aggravates H
Liu F; Zhang H; Zhang Z; Lu Y; Lu X
Eur J Pharmacol; 2019 Dec; 864():172668. PubMed ID: 31545986
[TBL] [Abstract][Full Text] [Related]
5. MiR-208a participates with sevoflurane post-conditioning in protecting neonatal rat cardiomyocytes with simulated ischemia-reperfusion injury via PI3K/AKT signaling pathway.
Shi HH; Wang ZQ; Zhang S
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):943-955. PubMed ID: 32017002
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-208a Correlates Apoptosis and Oxidative Stress Induced by H
Liu A; Sun Y; Yu B
Int Heart J; 2018 Jul; 59(4):829-836. PubMed ID: 29877301
[TBL] [Abstract][Full Text] [Related]
7. MiR-144 protects the heart from hyperglycemia-induced injury by regulating mitochondrial biogenesis and cardiomyocyte apoptosis.
Tao L; Huang X; Xu M; Yang L; Hua F
FASEB J; 2020 Feb; 34(2):2173-2197. PubMed ID: 31907983
[TBL] [Abstract][Full Text] [Related]
8. Metabolic labeling of cardiomyocyte-derived small extracellular-vesicle (sEV) miRNAs identifies miR-208a in cardiac regulation of lung gene expression.
Han C; Yang J; Zhang E; Jiang Y; Qiao A; Du Y; Zhang Q; An J; Sun J; Wang M; Nguyen T; Lal H; Krishnamurthy P; Zhang J; Qin G
J Extracell Vesicles; 2022 Oct; 11(10):e12246. PubMed ID: 36250966
[TBL] [Abstract][Full Text] [Related]
9. The Efficacy of Cardiac Anti-miR-208a Therapy Is Stress Dependent.
Eding JE; Demkes CJ; Lynch JM; Seto AG; Montgomery RL; Semus HM; Jackson AL; Isabelle M; Chimenti S; van Rooij E
Mol Ther; 2017 Mar; 25(3):694-704. PubMed ID: 28202391
[TBL] [Abstract][Full Text] [Related]
10. Effect of microRNA-208a on mitochondrial apoptosis of cardiomyocytes of neonatal rats.
Meng LD; Meng AC; Zhu Q; Jia RY; Kong QZ
Asian Pac J Trop Med; 2015 Sep; 8(9):747-51. PubMed ID: 26433661
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction.
Tony H; Yu K; Qiutang Z
Oxid Med Cell Longev; 2015; 2015():597032. PubMed ID: 26137188
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles-mediated transfer of miR-208a/b exaggerate hypoxia/reoxygenation injury in cardiomyocytes by reducing QKI expression.
Wang F; Yuan Y; Yang P; Li X
Mol Cell Biochem; 2017 Jul; 431(1-2):187-195. PubMed ID: 28283792
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol.
Gul R; Mahmood A; Luck C; Lum-Naihe K; Alfadda AA; Speth RC; Pulakat L
Obesity (Silver Spring); 2015 Nov; 23(11):2251-9. PubMed ID: 26381051
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of miR-208a in the heart.
Oliveira-Carvalho V; Carvalho VO; Bocchi EA
DNA Cell Biol; 2013 Jan; 32(1):8-12. PubMed ID: 23121236
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.
Callis TE; Pandya K; Seok HY; Tang RH; Tatsuguchi M; Huang ZP; Chen JF; Deng Z; Gunn B; Shumate J; Willis MS; Selzman CH; Wang DZ
J Clin Invest; 2009 Sep; 119(9):2772-86. PubMed ID: 19726871
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK).
Huang Y; Yang Y; He Y; Huang C; Meng X; Li J
Curr Pharm Des; 2016; 22(31):4868-4875. PubMed ID: 26861724
[TBL] [Abstract][Full Text] [Related]
17. miR-208a in Cardiac Hypertrophy and Remodeling.
Huang XH; Li JL; Li XY; Wang SX; Jiao ZH; Li SQ; Liu J; Ding J
Front Cardiovasc Med; 2021; 8():773314. PubMed ID: 34957257
[TBL] [Abstract][Full Text] [Related]
18. MiR-208a-3p aggravates autophagy through the PDCD4-ATG5 pathway in Ang II-induced H9c2 cardiomyoblasts.
Wang L; Ye N; Lian X; Peng F; Zhang H; Gong H
Biomed Pharmacother; 2018 Feb; 98():1-8. PubMed ID: 29241069
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.
Montgomery RL; Hullinger TG; Semus HM; Dickinson BA; Seto AG; Lynch JM; Stack C; Latimer PA; Olson EN; van Rooij E
Circulation; 2011 Oct; 124(14):1537-47. PubMed ID: 21900086
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart.
Wang BW; Wu GJ; Cheng WP; Shyu KG
PLoS One; 2014; 9(1):e84188. PubMed ID: 24392114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
